CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 8-K Event Executive or director change · Other events
- 4 Planned sale Chief Executive Officer sold 72,995 shares at $9.46 ($690,365)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale EVP & Chief Technology Officer sold 2,711 shares at $10.05 ($27,251)
- 4 Open-market sale EVP & Chief Financial Officer sold 6,008 shares at $9.89 ($59,404)
- 4 Planned sale EVP & Chief Technology Officer sold 12,296 shares at $10.05 ($123,521)
- 4 Grant or award Chief Executive Officer acquired 175,000 shares (grant or award)
- 4 Grant or award EVP & Chief Financial Officer acquired 40,000 shares (grant or award)
- 4 Planned sale EVP & Chief Medical Officer sold 14,568 shares at $10.05 ($146,344)
- 4 Planned sale Director sold 27,750 shares at an average $11.07 ($307,259)
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Material agreement · Results of operations
- 4 Planned sale Director sold 27,750 shares at an average $10.23 ($283,771)
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- 4 Planned sale EVP & Chief Medical Officer sold 3,321 shares at $10.24 ($34,006)
- SC 13G/A Stake Amended Statement of Ownership
Page 13 of 41 · 806 filings